JPRN-UMIN000007097已完成未知
Comparison of the Effect of GLP-1 Receptor Agonists on Diurnal Glycemic Profiles in Patients with Diabetes - Comparison of Liraglutide and Exenatide Evaluated by CGM
Kitano Hospital, The Tazuke Kofukai Medical Research Institute0 个研究点目标入组 40 人开始时间: 2012年1月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.The patients with serious complications 2.The patients who did not agree with this study 3.The patients with chronic kidney disease higher than stage 4 4.The patients with type 1 diabetes 5.Those who are not approved to be eligible to this study by corresponding researcher or co-researchers
研究者
相似试验
招募中
不适用
Comparing effects of a long acting GLP-1 receptor agonist liraglutide with a short acting GLP-1 receptor agonist lixisenatide on diabetic cardiac autonomic neuropathy and glycemic variability evaluated by power spectral analysis of 24-hr heart rate and continuous glucose monitoring.Type 2 diabetesJPRN-UMIN000017144Department of Endocrinology and Metabolism, Dokkyo Medical University30
进行中（未招募）
1 期
GLP-1 and hyperoxia for organ protection in heart surgeryWe investigate the efficacy of commercially available GLP-1 analog for reducing organ damage in patients undergoing heart surgery (i.e. coronary artery bypass grafting and/or aortic valve replacement).In addition we investigate the efficacy of restrictive versus liberal oxygenation (i.e. FiO2 50% versus FiO2 100%) for reducing organ damage during weaning after heart surgery. The study is a two-by-two factorial designed randomized clinical trial.MedDRA version: 20.0Level: LLTClassification code 10008937Term: Chronic ischemic heart disease, unspecifiedSystem Organ Class: 100000011627EUCTR2015-003050-41-DKRigshospitalet
已完成
不适用
The influence of GLP-1 receptor agonist on the heart rate using holter electrocardiography and power spectrum analysis on heart rate variabilityType 2 diabetesJPRN-UMIN000017770Dokkyomedical university nikko medical center50
进行中（未招募）
1 期
GLIDE: Gastric band and Liraglutide Intervention in Diabetes EvolutioThis trial will investigate the effects of the study treatment arms (gastric band + placebogastric band + liraglutide) on diabetes resolution in obese patients.MedDRA version: 14.1 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-001538-41-GBniversity of Birmingham200
进行中（未招募）
不适用
Effects of once-daily administered GLP-1 Receptoragonist Lixisenatide in combination with basal Insulin on glycemic control in patients with type-2 diabetes mellitus not achieving therapeutic targets with premixed insulin strategy10 patients (both gender) under treatment with premixed insulin (2-3 injections) and HbA1c>7% will be switched to basal insulin glargine (Lantus, once daily) and GLP-1 receptor agonist Lixisenatide (Lyxumia, once daily).EUCTR2013-005334-37-ATMedical University of Vienna / Medizinische Universität Wien